人红细胞生成素受体的研究进展
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:


Advance in the Rescarch of Human Erythropoietin Receptor
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    人红细胞生成素受体(hEPOR)是位于相对成熟阶段人体红系祖细胞表面的跨膜蛋白,它能专一性结合人红细胞生成素(hEPO),将促进细胞生长、增殖和分化的信号传导到膜内,该过程涉及了hEPOR自身及部分相关蛋白的磷酸化.hEPOR具有一些与其功能相关的保守结构,它的氨基酸序列与鼠EPOR(mEPOP)高度同源.EPOR因为膜外R129C突变或结合特定蛋白质而具有组成型活性.EPOR还与红白血病等多种血液病密切相关.

    Abstract:

    Human erythropoietin receptor (hEPOR) is a transmembrane protein which located in the surface of the relatively mature erythroid progenitor cells. It can promote the viability,proliferation and differentiation of the cells by specifically binding to erythropoietin(EPO),in which process the hEPOR itself and some other proteins will be phosphorylated. There are some conserved domains in hEPOR which is adapted to its function,The amino acid sequence of the human EPOR is 82% identical to that of the mouse protein. The EPOR can be constitutively activated by a single R129C mutation or binding to a special protein. It is also closely related to many blood diseases such as erythroleukemia.

    参考文献
    相似文献
    引证文献
引用本文

王少雄,董晨,华子春.人红细胞生成素受体的研究进展[J].生物化学与生物物理进展,1995,22(3):198-202

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:1994-06-03
  • 最后修改日期:1994-12-05
  • 接受日期:
  • 在线发布日期:
  • 出版日期: